These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6116337)

  • 21. [Morphological characteristics of D-galactosamine hepatitis].
    Popov A; Klouchek-Popova E; Stoilova M
    Eksp Med Morfol; 1983; 22(2):74-80. PubMed ID: 6667658
    [No Abstract]   [Full Text] [Related]  

  • 22. Ingestion of resistant starch protects endotoxin influx from the intestinal tract and reduces D-galactosamine-induced liver injury in rats.
    Morita T; Tanabe H; Takahashi K; Sugiyama K
    J Gastroenterol Hepatol; 2004 Mar; 19(3):303-13. PubMed ID: 14748878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury.
    Yoshida T; Abe K; Ikeda T; Matsushita T; Wake K; Sato T; Sato T; Inoue H
    Eur J Pharmacol; 2007 Dec; 576(1-3):136-42. PubMed ID: 17825282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted protection of hepatocytes from galactosamine toxicity in vivo.
    Keegan-Rogers V; Wu GY
    Cancer Chemother Pharmacol; 1990; 26(2):93-6. PubMed ID: 1693313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of Z-FA.FMK on D-galactosamine/TNF-alpha-induced liver injury in mice.
    Gezginci S; Bolkent S
    Cell Biochem Funct; 2007; 25(3):277-86. PubMed ID: 16850524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teas and other beverages suppress D-galactosamine-induced liver injury in rats.
    Sugiyama K; He P; Wada S; Saeki S
    J Nutr; 1999 Jul; 129(7):1361-7. PubMed ID: 10395599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural requirements for cytoprotective agents in galactosamine-induced hepatic necrosis.
    MacDonald JR; Gandolfi AJ; Sipes IG
    Toxicol Appl Pharmacol; 1985 Oct; 81(1):17-24. PubMed ID: 4049417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of total parenteral nutrition with nucleoside and nucleotide mixture on D-galactosamine-induced liver injury in rats.
    Ogoshi S; Iwasa M; Kitagawa S; Ohmori Y; Mizobuchi S; Iwasa Y; Tamiya T
    JPEN J Parenter Enteral Nutr; 1988; 12(1):53-7. PubMed ID: 3125356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 45Calcium uptake during the transition from reversible to irreversible liver injury induced by D-galactosamine in vivo.
    Schiessel C; Forsthove C; Keppler D
    Hepatology; 1984; 4(5):855-61. PubMed ID: 6207090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ameliorative effect of an urinary preparation on acetaminophen and D-galactosamine induced hepatotoxicity in rats.
    Lai TY; Wu YW; Lin WC
    Am J Chin Med; 1999; 27(1):73-81. PubMed ID: 10354819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatoprotective effects of purple potato extract against D-galactosamine-induced liver injury in rats.
    Han KH; Hashimoto N; Shimada K; Sekikawa M; Noda T; Yamauchi H; Hashimoto M; Chiji H; Topping DL; Fukushima M
    Biosci Biotechnol Biochem; 2006 Jun; 70(6):1432-7. PubMed ID: 16794324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electron optic studies on galactosamine-induced lesions in the rat liver].
    Meyer-Burg J; Hirner A
    Klin Wochenschr; 1971 Nov; 49(22):1240-1. PubMed ID: 5132333
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective effects of coffee-derived compounds on lipopolysaccharide/D-galactosamine induced acute liver injury in rats.
    Akashi I; Kagami K; Hirano T; Oka K
    J Pharm Pharmacol; 2009 Apr; 61(4):473-8. PubMed ID: 19298694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of vitamin E in rats with acute liver injury.
    Sclafani L; Shimm P; Edelman J; Seifter E; Levenson SM; Demetriou AA
    JPEN J Parenter Enteral Nutr; 1986; 10(2):184-7. PubMed ID: 3959325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity of D-galactosamine for rat hepatocytes in monolayer culture.
    Tran-Thi TA; Phillips J; Falk H; Decker K
    Exp Mol Pathol; 1985 Feb; 42(1):89-116. PubMed ID: 2857129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT1 plays an essential role in LPS/D-galactosamine-induced liver apoptosis and injury.
    Kim WH; Hong F; Radaeva S; Jaruga B; Fan S; Gao B
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G761-8. PubMed ID: 12816762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of the liver protecting compound ES 914 on D-galactosamine induced experimental hepatitis in the rat].
    Wegmann A; Chariatte N; Renker H; Dittrich A
    Arzneimittelforschung; 1979; 29(1):68-70. PubMed ID: 582121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality.
    Oberholzer A; Oberholzer C; Bahjat FR; Edwards CK; Moldawer LL
    J Endotoxin Res; 2001; 7(5):375-80. PubMed ID: 11753206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ongoing hepatocellular regeneration and resiliency toward galactosamine hepatotoxicity.
    Abdul-Hussain SK; Mehendale HM
    Arch Toxicol; 1992; 66(10):729-42. PubMed ID: 1290405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by D-galactosamine.
    Lemire JM; Shiojiri N; Fausto N
    Am J Pathol; 1991 Sep; 139(3):535-52. PubMed ID: 1716045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.